COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Fundamental Risk Analysis including financial ratios, debt levels, liquidity, and sustainability metrics. Compare against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Fundamental Risk Analysis - Compare Against 2127.T

Comparison against 2127.T

None 3391.T 3141.T 3088.T 2127.T 9843.T

Gauges a company's financial stability and solvency. Value investors pay close attention to leverage and liquidity risk, ensuring the company has enough cushion to withstand downturns without impairing shareholder value.

Debt-to-Equity Ratio

0.11

Decreased from previous period

Higher D/E at 1.1-1.25x 2127.T's 0.09. Bruce Berkowitz would look for hidden assets justifying this higher leverage.

Net Debt-to-EBITDA

-0.67

Decreased from previous period

Both companies show net cash positions. Charlie Munger would investigate if industry economics justify such conservative capitalization.

Interest Coverage Ratio

355.26

Increased from previous period

Coverage below 50% of 2127.T's 1024.61. Jim Chanos would check for potential debt service risks.

Current Ratio

0.60

Increased from previous period

Current ratio below 50% of 2127.T's 2.69. Jim Chanos would check for potential working capital crisis.

Intangibles-to-Total-Assets Ratio

0.10%

Increased from previous period

Much higher intangibles at 1.25-1.5x 2127.T's 0.07%. Bill Ackman would scrutinize acquisition premiums paid.

Select Chart Metric:

3349.T Fundamental Risk Analysis - Compare Against 2127.T

Comparison against 2127.T

None 3391.T 3141.T 3088.T 2127.T 9843.T

Debt-to-Equity Ratio

0.11

Decreased from previous period

Higher D/E at 1.1-1.25x 2127.T's 0.09. Bruce Berkowitz would look for hidden assets justifying this higher leverage.

Net Debt-to-EBITDA

-0.67

Decreased from previous period

Both companies show net cash positions. Charlie Munger would investigate if industry economics justify such conservative capitalization.

Interest Coverage Ratio

355.26

Increased from previous period

Coverage below 50% of 2127.T's 1024.61. Jim Chanos would check for potential debt service risks.

Current Ratio

0.60

Increased from previous period

Current ratio below 50% of 2127.T's 2.69. Jim Chanos would check for potential working capital crisis.

Intangibles-to-Total-Assets Ratio

0.10%

Increased from previous period

Much higher intangibles at 1.25-1.5x 2127.T's 0.07%. Bill Ackman would scrutinize acquisition premiums paid.

Select Chart Metric: